Eastman Chemical (EMN) has seen recent share price momentum with a 21.89% return over 90 days, despite a 19.26% decline over the past year. The stock trades close to analyst targets but is at a modeled intrinsic discount, leading to a “3% Overvalued” narrative with a fair value of $73.35. However, a market multiple analysis suggests the stock is undervalued compared to peers, trading at 18.2x earnings versus a peer average of 32.6x.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Assessing Eastman Chemical (EMN) Valuation After Recent Share Price Momentum
Eastman Chemical (EMN) has seen recent share price momentum with a 21.89% return over 90 days, despite a 19.26% decline over the past year. The stock trades close to analyst targets but is at a modeled intrinsic discount, leading to a “3% Overvalued” narrative with a fair value of $73.35. However, a market multiple analysis suggests the stock is undervalued compared to peers, trading at 18.2x earnings versus a peer average of 32.6x.